SMTL ID : 4dfn.1

Crystal structure of spleen tyrosine kinase complexed with an adamantylpyrazine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

monomer

Ligands

1 x 0K1: 3-amino-6-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]-N-[(1R,2r,3S,5s,7s)-5-hydroxyadamantan-2-yl]pyrazine-2-carboxamide(Non-covalent)

0K1.1: 16 residues within 4Å: Chain A: L.15, G.16, F.20, V.23, A.38, V.71, M.86, E.87, M.88, A.89, G.92, P.93, K.96, L.139, S.149, D.150 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.15, A:L.15, A:F.20, A:F.20, A:V.23, A:P.93, A:D.150 Hydrogen bonds: A:E.87, A:A.89, A:K.96

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Forns, P. et al., Pyrazine-based Syk kinase inhibitors. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-04-25

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence